OHSU
Return to Listing

5 result(s) for Lung Cancers

PI Name Protocol # Title
Ariel Lopez-Chavez IRB00007252 Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics with Non-Small Cell Lung Cancer
Jeremy Cetnar IRB00007669 An Open Label, Multi-center, IRESSA Clinical Access Program of Gefitinib 250 mg (IRESSA) for the Continued Treatment of Patients in the United States Who Are Currently Benefiting or Have Benefited from Gefitinib Treatment
Ariel Lopez-Chavez IRB00009059 National Lung Cancer Partnership- Lung Cancer Mutation Consortium
Jeremy Cetnar IRB00009512 A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) versus Docetaxel in Previously Treated Subjects with Non-Small Cell Lung Cancer
Jeremy Cetnar IRB00009657 NP28761: A Phase I/II Study of the ALK Inhibitor CH5424802/RO5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer Previously Treated with Crizotinib
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program